Israel Active

Kytera is another Israeli startup that has developed innovative sensor technology to keep a close eye on at-risk seniors. It also collects anonymous data that can be used to provide vital research on specific illnesses or medications.

I reported on Israel’s V-Wave when it implanted its first heart shunt to treat congestive heart failure patients. It has since successfully treated over 30 patients. V-Wave has just raised $28 million to expand clinical evaluation, development and production.

Professor Yonina Eldar at Israel’s Technion is developing an innovative portable ultrasound system that transmits scans to the treating physician immediately. Scans can be performed in disaster areas, at road accidents, and in developing countries where the medical infrastructure is limited.

Another great innovation from Hadassah / Hebrew University of Jerusalem’s BioDesign students. Their SenseGo socks contain dozens of micro-fabricated pressure sensors that send warnings via smartphone of incorrect posture or ill-fitting shoes that may cause foot ulcers to develop.

Israel’s Ninispeech enables people who stutter to take control over their speech, using unique mobile feedback technology. NiNiSpeech catalyzes assimilation of speech strategies, encourages communication, sharpens learning curve, and maximizes success rate. 3 top Israeli doctors are cofounders, including Dr Yoav Medan, ex-CTO of Israeli focused ultrasound specialists InSightec.

Israeli startup Nexense manufactures a device to treat snoring and sleep apnea. Worn as a chest strap or wristwatch, it detects snoring or sleep apnea and then vibrates to help the patient resume breathing or stop snoring, without waking him / her up.

Cancer charity Ezer Mizion has a unique WhatsApp Group. “Linked to Life” has about 4,000 volunteers who respond fast to (sometimes life-threatening) problems. Like forgotten medication or a premature baby who needs special formula.

Scientists at the Hebrew University of Jerusalem have destroyed the HIV virus using peptides containing multiple copies of the virus’ DNA. Combined with existing HIV medications the peptides activate the cell's self-destruction mechanisms. After two weeks there was no sign of the virus. Human trials will commence in a few months.

Israel’s MobileODT has donated 20 of its Enhanced Visual Assessment (EVA) cervical cancer screening devices to healthcare providers in Kenya. On World Cancer Day (4th Feb), nurses trained by the NGO Rotary International aim to screen over 700 Kenyan women using the devices.

Researchers at Israel’s Bar-Ilan University are developing gold nano-rods to help identify and treat blocked arteries. The tiny gold particles are absorbed by macrophages (cancer-eating white blood cells) to illuminate problem areas. Combining them with good cholesterol can then clear the blockages.